The PE Ratio as of December 2024 (TTM) for Editas Medicine, Inc. (EDIT) is -0.48

According to Editas Medicine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.48. This represents a change of -87.93% compared to the average of -3.98 of the last 4 quarters.

Editas Medicine, Inc. (EDIT) Historical PE Ratio (quarterly & annually)

How has EDIT PE Ratio performed in the past?

The mean historical PE Ratio of Editas Medicine, Inc. over the last ten years is -12.21. The current -0.48 PE Ratio has changed 293.07% with respect to the historical average. Over the past ten years (40 quarters), EDIT's PE Ratio was at its highest in in the September 2020 quarter at 55.75. The PE Ratio was at its lowest in in the September 2018 quarter at -23.70.

Editas Medicine, Inc. (EDIT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Editas Medicine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Editas Medicine, Inc. (EDIT) Average PE Ratio

How has EDIT PE Ratio performed in the past?

The current PE Ratio of Editas Medicine, Inc. (EDIT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Editas Medicine, Inc. (EDIT) PE Ratio vs. Peers

How is EDIT’s PE Ratio compared to its peers?

Editas Medicine, Inc.’s PE Ratio is greater than Beam Therapeutics Inc. (-16.61), greater than CRISPR Therapeutics AG (-14.41), greater than Caribou Biosciences, Inc. (-1.02), greater than Verve Therapeutics, Inc. (-2.48), greater than Intellia Therapeutics, Inc. (-2.34), greater than Prime Medicine, Inc. (-1.49), greater than Vertex Pharmaceuticals Incorporated (-219.49), greater than Ginkgo Bioworks Holdings, Inc. (-0.74), greater than Allogene Therapeutics, Inc. (-1.49), greater than Sana Biotechnology, Inc. (-1.33),

Build a custom stock screener for Editas Medicine, Inc. (EDIT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Editas Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Editas Medicine, Inc. (EDIT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Editas Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.